Clinical Trials Browser

Phase 2 × Neurotoxicity Syndromes × 90 days × Clear all

NCT01949662 2026-02-13

Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer

Phase 2 Active not recruiting

93 enrolled 14 charts

Other hematologic neoplasm

Delirium, Hematologic Neoplasms, Neurotoxicity Syndromes

NCT07333976 2026-01-12

o Tadalafil for Prevention of Docetaxel-Induced Peripheral Neuropathy in Prostate Cancer

Phase 2 Completed

Peripheral Nervous System Diseases, Neurotoxicity Syndromes